DEPLOYDatabase

Robot model

Johnson & Johnson Ottava

Next-generation surgical robot in development by J&J/Ethicon.

Manufacturer
Johnson & Johnson
Form factor
surgical
Maturity
commercial
Lifecycle
active
Deployments
3

The verified answer

As of Sep 2026, DEPLOY verifies Johnson & Johnson Ottava, a surgical by Johnson & Johnson (commercial): 3 verified deployments on record. 1 source back the record.

Overview

Next-generation surgical robot in development by J&J/Ethicon. 6-arm configuration, general surgery focus.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Product

MONATCH bronchoscopic robot, OTTAVA surgical robotics

Status

Pre-market: FDA De Novo submitted Jan 7 2026; NOT cleared; zero installed base.

Stock listing

NYSE: JNJ

Developing division

MedTech/Ethicon

Company type

Global healthcare company

Revenue

\8B (2025, NYSE: JNJ)

Data & sources

Web sources

1

1 source backing this record.View all →

Availability and pricing

Availability
Not sold (internal use)
Price
Not publicly disclosed
Units in field
Not disclosed
Sales model
Not disclosed
Lead time
Not disclosed

Pricing

No verified price is on record for Johnson & Johnson Ottava. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Deployments (3)

Free to use on your site, with a link back to DEPLOY.

Johnson & Johnson Ottava on the deployment map

View the global map

Where Johnson & Johnson Ottava is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

  • Incident recordedJul 22, 2026

    FDA clears Johnson & Johnson Ottava robotic surgical system for soft tissue surgeries

  • Incident recordedJul 22, 2026

    FDA grants De Novo authorization to Johnson & Johnson OTTAVA robotic surgical system for...

  • Incident recordedJul 22, 2026

    FDA clears J&J Ottava surgical robot for US launch following de novo submission

  • Incident recordedJul 22, 2026

    FDA grants De Novo marketing authorization to J&J Ottava surgical robot

  • Verified media addedVerifiedJun 11, 2026

    The Next Era of Surgery | J&J MedTech

Full change history →

Deployment-verified media (1)

PRIMARY SOURCE
Courtesy of Johnson & Johnson

Johnson & Johnson MedTech's surgical-robotics brand film, which features its Ottava soft-tissue surgical robot (no Ottava-specific video exists on the official channel). A surgeon-teleoperated system, not autonomous.

From deployment: United States

Safety record

5 incidents on record (3 moderate, 2 minor). Most recent: Jul 2026.

moderate
3
minor
2

Most recent: Jul 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting Johnson & Johnson Ottava (5)

Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Sources (1)

  1. https://www.jnj.com/

Compare Johnson & Johnson Ottava

Common questions

What is Johnson & Johnson Ottava?
Next-generation surgical robot in development by J&J/Ethicon. 6-arm configuration, general surgery focus.
How much does Johnson & Johnson Ottava cost?
Johnson & Johnson Ottava's price is not publicly disclosed. DEPLOY has no verified price on record for Johnson & Johnson Ottava from Johnson & Johnson. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Johnson & Johnson Ottava actually deployed in the real world?
Yes. Johnson & Johnson Ottava is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Johnson & Johnson Ottava?
Johnson & Johnson Ottava is made by Johnson & Johnson, based in New Brunswick, New Jersey, USA, founded in 1886.
Where is Johnson & Johnson Ottava deployed?
3 verified deployments of Johnson & Johnson Ottava are on the DEPLOY registry, including at California, United States, New Brunswick.
Can you buy Johnson & Johnson Ottava?
Johnson & Johnson Ottava is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to Johnson & Johnson Ottava?
On the DEPLOY registry, comparable surgical robots to Johnson & Johnson Ottava include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does Johnson & Johnson Ottava compare to da Vinci (and Ion)?
Johnson & Johnson Ottava and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Johnson & Johnson Ottava has 3 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Johnson & Johnson Ottava a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Johnson & Johnson Ottava ranks in roughly the top 19% of surgical models tracked by the registry.
What is Johnson & Johnson Ottava's maturity stage?
Johnson & Johnson Ottava is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Johnson & Johnson Ottava safe?
Johnson & Johnson Ottava has 5 active incidents on record in the DEPLOY registry. 5 incidents on record (3 moderate, 2 minor). Most recent: Jul 2026. Retracted incidents are excluded from this count.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-12

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-07-12

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Johnson & Johnson Ottava.

Recent coverage

Johnson & Johnson Ottava in third-party press